Track subtle changes in your body with Health Guardian features on Pixel and Fitbit - blog.google

The company also announced a new metal mesh band for the Fitbit Air. Google is rolling out a pair of updates to improve automatic activity tracking for its wearables and bring more health features to its latest Fitbits. The company announced today that Health Guardian, which it introduced over the summer for the Pixel Watch, is coming to the Fitbit Air for Google Health Premium subscribers later this month. The service will also be available for the new Fitbit Edge at that time under the Premium subscription. Also later this month, Google says it's rolling out an upgrade to automatic activity tracking for the Fitbit Air, Fitbit Edge and Pixel Watches 3, 4 and 5 that nearly doubles its accuracy and expands the list of recognized workouts from 10 to over 100.

Perhaps the single most important finding of the independent review into mental health, ADHD and autism in England, published last Friday, is that mental distress across the population, and particularly young people, has substantially worsened. Its chair, Prof Peter Fonagy, told the BBC that the former health secretary Wes Streeting had been “completely wrong” to suggest that conditions and disorders were being overdiagnosed. Mr Streeting acknowledged his mistake. But some rightwing politicians and commentators have leapt on the notion that medicalisation of ordinary states of mind is behind the huge rise in young people seeking help. This review should bury that idea. Instead, this should be a moment to face facts. First, that the rises in psychological distress, and the need for support with neurodevelopmental differences, are real and tied to social changes. Second, that current services are not up to what is being asked of them. Fifteen years after the phrase “parity of esteem” gained prominence – the idea being that people with mental ill health have equivalent entitlements to those with physical illnesses – it is a long way from being realised.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.